Goldman Sachs’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7M | Buy |
|
|||||
|
2025
Q1 | $5.23M | Sell |
|
|||||
|
2024
Q4 | $6.29M | Sell |
|
|||||
|
2024
Q3 | $22.2M | Buy |
|
|||||
|
2024
Q2 | $11.1M | Buy |
|
|||||
|
2024
Q1 | $6.36M | Sell |
|
|||||
|
2023
Q4 | $6.31M | Sell |
|
|||||
|
2023
Q3 | $4.67M | Sell |
|
|||||
|
2023
Q2 | $4.57M | Buy |
|
|||||
|
2023
Q1 | $2.81M | Buy |
|
|||||
|
2022
Q4 | $2.05M | Sell |
|
|||||
|
2022
Q3 | $1.65M | Buy |
|
|||||
|
2022
Q2 | $1.08M | Sell |
|
|||||
|
2022
Q1 | $2.05M | Sell |
|
|||||
|
2021
Q4 | $2.77M | Sell |
|
|||||
|
2021
Q3 | $3.65M | Buy |
|
|||||
|
2021
Q2 | $4.19M | Sell |
|
|||||
|
2021
Q1 | $4.5M | Buy |
|
|||||
|
2020
Q4 | $1.33M | Buy |
|
|||||
|
2020
Q3 | $939K | Sell |
|
|||||
|
2020
Q2 | $1.37M | Sell |
|
|||||
|
2020
Q1 | $1.75M | Sell |
|
|||||
|
2019
Q4 | $5.07M | Buy |
|
|||||
|
2019
Q3 | $930K | Sell |
|
|||||
|
2019
Q2 | $1.24M | Sell |
|
|||||
|
2019
Q1 | $2.7M | Sell |
|
|||||
|
2018
Q4 | $3.64M | Sell |
|
|||||
|
2018
Q3 | $4.89M | Buy |
|
|||||
|
2018
Q2 | $2.61M | Buy |
|
|||||
|
2018
Q1 | $1.41M | Sell |
|
|||||
|
2017
Q4 | $2.07M | Buy |
|
|||||
|
2017
Q3 | $841K | Buy |
|
|||||
|
2017
Q2 | $604K | Sell |
|
|||||
|
2017
Q1 | $658K | Buy |
|
|||||
|
2016
Q4 | $555K | Buy |
|
|||||
|
2016
Q3 | $222K | Sell |
|
|||||
|
2016
Q2 | $522K | Sell |
|
|||||
|
2016
Q1 | $1.09M | Buy |
|
|||||
|
2015
Q4 | $1.12M | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $721K | Buy |
|